Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-049710
Filing Date
2024-04-29
Accepted
2024-04-29 14:07:07
Documents
13
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A rkda-20231231.htm   iXBRL 10-K/A 1171087
2 EX-31.1 rkda-ex31_1.htm EX-31.1 8184
3 EX-31.2 rkda-ex31_2.htm EX-31.2 8244
  Complete submission text file 0000950170-24-049710.txt   1457562

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20231231.xsd EX-101.SCH 52876
16 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20231231_htm.xml XML 11301
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37383 | Film No.: 24889424
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)